Regencell Bioscience Holdings Limited
5.85USD
-0.9700 (-14.22%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| FY | — | — | — | — | — |
| Q1 | — | — | — | — | — |
| Q2 | — | — | — | — | — |
| Q3 | — | — | — | — | — |
| Q4 | — | — | — | — | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| FY | -.015 | -.012 | -.009 | -.007 | — |
| Q1 | — | — | — | — | — |
| Q2 | — | — | — | — | — |
| Q3 | — | — | — | — | — |
| Q4 | — | — | — | — | — |
Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). No forward consensus is cached for this security yet. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.